AC Immune SA (ACIU)
2.63
-0.05
(-1.87%)
USD |
NASDAQ |
Sep 18, 16:00
2.65
+0.02
(+0.76%)
After-Hours: 20:00
AC Immune Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 20.10M |
| September 30, 2025 | 26.86M |
| June 30, 2025 | 29.18M |
| March 31, 2025 | 3.368M |
| December 31, 2024 | -2.899M |
| September 30, 2024 | -7.232M |
| June 30, 2024 | -82.92M |
| March 31, 2024 | -26.95M |
| December 31, 2023 | 26.04M |
| September 30, 2023 | 6.070M |
| June 30, 2023 | -4.379M |
| March 31, 2023 | 46.26M |
| December 31, 2022 | 5.199M |
| September 30, 2022 | -5.336M |
| June 30, 2022 | 25.37M |
| March 31, 2022 | -0.5845M |
| December 31, 2021 | -23.43M |
| September 30, 2021 | -0.2456M |
| June 30, 2021 | -33.67M |
| March 31, 2021 | -0.8719M |
| December 31, 2020 | 5.076M |
| Date | Value |
|---|---|
| September 30, 2020 | 16.50M |
| June 30, 2020 | 9.988M |
| March 31, 2020 | -0.2189M |
| December 31, 2019 | -5.389M |
| September 30, 2019 | -11.46M |
| June 30, 2019 | -0.0452M |
| March 31, 2019 | -50.67M |
| December 31, 2018 | -30.43M |
| September 30, 2018 | -0.1439M |
| June 30, 2018 | -0.3695M |
| March 31, 2018 | -1.223M |
| December 31, 2017 | 0.0397M |
| September 30, 2017 | -0.3165M |
| June 30, 2017 | -0.9505M |
| March 31, 2017 | -0.6388M |
| December 31, 2016 | -0.2693M |
| September 30, 2016 | -0.312M |
| June 30, 2016 | -0.1052M |
| March 31, 2016 | -0.2113M |
| December 31, 2015 | 0.0015M |
| September 30, 2015 | -0.1236M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Precigen, Inc. | 26.69M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| Aldeyra Therapeutics, Inc. | -0.0231M |
| BeOne Medicines Ltd. | -49.41M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -34.77% |